{"id":169,"date":"2019-10-17T17:02:07","date_gmt":"2019-10-17T21:02:07","guid":{"rendered":"https:\/\/opentextbc.ca\/nursingpharmacology\/chapter\/4-5-ans-medication-classes-and-nursing-considerations\/"},"modified":"2023-08-01T14:26:20","modified_gmt":"2023-08-01T18:26:20","slug":"4-5-ans-medication-classes-and-nursing-considerations","status":"publish","type":"chapter","link":"https:\/\/opentextbc.ca\/nursingpharmacology\/chapter\/4-5-ans-medication-classes-and-nursing-considerations\/","title":{"raw":"4.5 ANS Medication Classes and Nursing Considerations","rendered":"4.5 ANS Medication Classes and Nursing Considerations"},"content":{"raw":"Classes of medication, categorized according to neuroreceptor, are further discussed in more detail below. Figure 4.5a summarizes how ANS drugs are classified.<\/a>\r\n\r\n[caption id=\"attachment_168\" align=\"aligncenter\" width=\"600\"]\"A Figure 4.5a Classification of drugs acting on the ANS <\/em>[Figure 4.5a Image Description]<\/a>
<\/em>[\/caption]Table 4.5[footnote]This work is a derivative of Daily Med<\/a> by U.S. National Library of Medicine<\/a> in the public domain<\/a>[\/footnote] further contrasts agonist and antagonist medications for each ANS neuroreceptor.\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n
\r\n

Table 4.5 Comparison of Prototype Medications that Stimulate Versus Inhibit PNS and SNS Receptors<\/h2>\r\n<\/caption>\r\n

Receptor<\/th>\r\nStimulation (Agonist)<\/th>\r\nInhibition (Antagonist)<\/th>\r\n<\/tr>\r\n
Nicotinic<\/th>\r\n\r\n\r\n
    \r\n \t
  • Not clinically applicable<\/li>\r\n<\/ul>\r\n<\/td>\r\n<\/tr>\r\n
Muscarinic<\/th>\r\n\r\n\r\n
Alpha-1\r\n(found in smooth muscles)<\/th>\r\n\r\n\r\n
Alpha-2\r\n(found in brain and periphery)<\/th>\r\n\r\n\r\n
    \r\n \t
  • Limited clinical use<\/li>\r\n<\/ul>\r\n<\/td>\r\n<\/tr>\r\n
Beta-1\r\n(found on heart and kidneys)<\/th>\r\n\r\n\r\n
Beta-2\r\n(found on the lungs)<\/th>\r\n\r\n\r\n
Catecholamines stimulate multiple adrenergic receptors<\/th>\r\n\r\n\r\n